Duke Neurosurgery received $8.3 million from the National Institutes of Health (NIH) in 2024 to fund research to advance science and patient care.
Based on this level of funding, the department was ranked ninth among neurosurgery clinical departments in the U.S. according to the Blue Ridge Institute for Medical Research.
The work of Duke Neurosurgery faculty labs can and have led to groundbreaking treatments for spine disorders, brain tumors, epilepsy, movement disorders, traumatic brain injuries, and pediatric brain tumors and injuries.
“NIH funding is the backbone of transformative scientific discovery,” said Mary E. Klotman, MD, executive vice president for health affairs at Duke University and dean of the School of Medicine. “These investments empower our researchers to push the boundaries of medicine. However, research isn’t just about bold ideas — it requires laboratories, data infrastructure, and skilled teams who bring science to life. NIH support of these essential foundations has been critical in turning these discoveries into real and lasting improvements in human health.”
The NIH is the largest public funder of biomedical research globally, fueling scientific research and translating knowledge into improvements for all.